Conversely, secretory CLU knockdown enhanced DNA damage-induced cell death in breast cancer cells, suggesting that BHLHE40 promoted cell survival by up-regulating secretory CLU to reduce the apoptotic response to DNA damage, providing insights into their roles in breast cancer progression. This evidence concerns the gene CLU and breast carcinoma.